Clinical trial
A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy…
NCT00390689 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00390689 |
|---|---|
| Title | A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS. |
| Official title | A Randomised, Double-blind Study to Evaluate the Efficacy and Safety of Pramipexole at Fixed Doses of 0.25 mg, 0.5 mg, and 0.75 mg in Patients With Idiopathic Restless Legs Syndrome for 6 Weeks, Followed by a 46-week Open-label Long-term Study |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Idiopathic Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Pramipexole 0.125 mg tablet, Pramipexole 0.5 mg tablet |
| Enrollment | 154 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2008 |
| First posted | Oct 20, 2006 |
| Last update posted | Jul 2, 2014 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: